蝙蝠翼乳房固定术在即刻假体乳房重建中的应用:为癌症患者带来的美学改善
该回顾性队列研究纳入2015年至2020年单机构188例患者共324次乳房手术,比较同期蝙蝠翼乳房固定术与标准即刻假体乳房重建。两组血肿、血清肿、严重感染、皮肤或乳头坏死及假体取出率均无统计学显著差异,蝙蝠翼组轻微感染率较高(10.0% vs 3.7%,P=0.03)。作者认为同期蝙蝠翼乳房固定术可安全实施,并为重度下垂或巨乳症患者提供乳头保留乳房切除术的选择。
要点
- 蝙蝠翼组与标准组并发症率相当,仅轻微感染率蝙蝠翼组较高(10.0% vs 3.7%,P=0.03)。
- 两组血肿、血清肿、严重感染、皮肤或乳头坏死、假体取出率均无统计学显著差异。
- 作者认为同期蝙蝠翼乳房固定术可安全用于即刻假体乳房重建,并改善重度下垂或巨乳症患者美学效果。
核心结论
- 作者证明同期蝙蝠翼乳房固定术可在即刻乳房重建时安全实施,并发症率与标准重建相当,并改善重度下垂或巨乳症患者的美学效果。
- 该技术使原本被排除的乳房下垂患者有机会接受乳头保留乳房切除术。
研究设计与样本
- 回顾性病历审查,纳入2015年至2020年单机构接受即刻假体乳房重建的患者。
- 共324次乳房手术(188例患者),分为蝙蝠翼乳房固定术组(80次)与标准重建组(244次)。
主要发现
- 蝙蝠翼组与标准组患者特征相似,但蝙蝠翼组乳房下垂程度更重,标准组接受辅助化疗者更多。
- 平均随访15.9个月(范围3.19至55.20个月)。
- 血肿发生率蝙蝠翼组1.3% vs 标准组3.3%(P=0.34),血清肿5.0% vs 8.2%(P=0.34),严重感染8.8% vs 9.0%(P=0.94),皮肤或乳头坏死6.3% vs 11.5%(P=0.18),假体取出11.3% vs 14.8%(P=0.43),均无统计学显著差异。
- 轻微感染率蝙蝠翼组10.0% vs 标准组3.7%(P=0.03),蝙蝠翼组较高。
临床怎么用
- 作者认为同期蝙蝠翼乳房固定术可安全用于即刻假体乳房重建,并为重度下垂或巨乳症患者提供乳头保留乳房切除术的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Historically, many patients with breast ptosis have been excluded from nipple-sparing mastectomies. By performing mastopexy at the time of immediate reconstruction, more patients with breast ptosis can be considered for nipple-sparing mastectomies. The authors review their experience of simultaneous batwing mastopexy performed at the time of immediate implant-based reconstruction. METHODS: Using retrospective chart review, the authors identified patients who underwent immediate implant-based breast reconstruction from 2015 through 2020 at a single institution. The patients were divided into two cohorts-batwing mastopexy and standard reconstruction (no mastopexy)-and compared. RESULTS: A total of 324 breast operations in 188 patients were included (80 concurrent batwing and 244 standard implant-based reconstructions). Patient characteristics were similar between the groups, except that patients in the batwing group had greater ptosis and more patients in the standard group underwent adjuvant chemotherapy. Mean follow-up was 15.9 months (range, 3.19 to 55.20 months). Complication rates were comparable in the batwing and standard groups, with no statistically significant differences in rates of hematoma (1.3 versus 3.3 percent; = 0.34), seroma (5.0 versus 8.2 percent; p = 0.34), major infection (8.8 versus 9.0 percent; p = 0.94), skin or nipple necrosis (6.3 versus 11.5 percent; p = 0.18), or explantation (11.3 versus 14.8 percent; p = 0.43). The rate of minor infections was higher in the group with concurrent batwing mastopexy (10.0 versus 3.7 percent; p = 0.03). CONCLUSIONS: The authors demonstrate that simultaneous batwing mastopexy can be performed safely at the time of immediate breast reconstruction. This technique provides comparable complication rates, improves aesthetic outcomes in patients with significant ptosis or macromastia, and allows nipple-sparing mastectomy to be an option for those who would otherwise be excluded. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Kadakia N, Kubiak JW, Landau MJ, et al. The Batwing Mastopexy in Immediate Implant-Based Breast Reconstruction: An Aesthetic Enhancement for Patients with Cancer. Plast Reconstr Surg. 2022. PMID: 35766828. doi:10.1097/PRS.0000000000009380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。